Centre Hospitalier Departemental Vendee
chd-vendee.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
82
Active
15
Phase 3
7
Total enrollment
30,606
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Corticosteroid | — | — | — | — | 2 | ||
| Hyaluronic acid | — | — | — | — | — | 1 | |
| Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl® | — | — | — | — | — | 1 |
Next readouts
- 2026-05-31
- 2026-12-19
- 2028-03
Top conditions
- Cardiac Arrest4
- Pregnancy3
- Ventilator-associated Pneumonia3
- Acute Respiratory Failure3
- Shock3
- Breast Cancer2
- Delivery2
- Kidney Failure, Chronic2
Frequently asked questions about Centre Hospitalier Departemental Vendee
- How many clinical trials does Centre Hospitalier Departemental Vendee have on ClinicalTrials.gov?
- Centre Hospitalier Departemental Vendee is listed as the lead sponsor on 82 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre Hospitalier Departemental Vendee's trials are in Phase 3?
- 7 of Centre Hospitalier Departemental Vendee's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Centre Hospitalier Departemental Vendee focus on?
- Centre Hospitalier Departemental Vendee's most-studied conditions on ClinicalTrials.gov are Cardiac Arrest, Pregnancy, Ventilator-associated Pneumonia, Acute Respiratory Failure, Shock.
- When are Centre Hospitalier Departemental Vendee's next clinical trial readouts?
- Centre Hospitalier Departemental Vendee has 3 upcoming primary-completion readouts tracked here; the soonest is “Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders”, expected around 2026-05-31.